Amanote Research

Amanote Research

    RegisterSign In

Developments in the Management of Advanced Soft-Tissue Sarcoma &Ndash; Olaratumab in Context

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s127609
Full Text
Open PDF
Abstract

Available in full text

Categories
OncologyPharmacology
Date

February 1, 2018

Authors
Gianluca MoronciniElena MaccaroniIlaria FiordolivaChiara PelleiArmando GabrielliRossana Berardi
Publisher

Informa UK Limited


Related search

Olaratumab in Soft Tissue Sarcoma – Current Status and Future Perspectives

European Journal of Cancer
Cancer ResearchOncology
2018English

Principles in Management of Soft Tissue Sarcoma

Advances in Surgery
Surgery
2015English

Olaratumab and Doxorubicin for the Treatment of Metastatic Soft Tissue Sarcoma: A Retrospective Case Series

Precision and Future Medicine
2019English

Immunotherapy in Soft-Tissue Sarcoma

Current Oncology
Oncology
2020English

Efficacy of Trabectedin in Advanced Soft Tissue Sarcoma: Beyond Lipo- And Leiomyosarcoma

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Update on Systemic Therapy for Advanced Soft Tissue Sarcoma

Current Oncology
Oncology
2020English

Imaging in Retroperitoneal Soft Tissue Sarcoma

Journal of Surgical Oncology
MedicineSurgeryOncology
2017English

Prognostic Factors in Soft Tissue Sarcoma

2011English

Erratum To: New Drug Developments for Patients With Metastatic Soft Tissue Sarcoma

Current Oncology Reports
Oncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy